22.418 makale bulundu

Gelişmiş parkinson hastalığı olan hastalarda sürekli jejunal levodopa infüzyonu: motor ve motor olmayan komplikasyonların pratik yönleri ve sonuçları.

Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications.

Eggert K, Schrader C, Hahn M, Stamelou M, Rüssmann A, Dengler R, Oertel W, Odin P.

Clin Neuropharmacol · 2008-05-01

DOI: 10.1097/wnf.0b013e31814b113ePMID: 18520982

Nörobilimcinin erime potası: immünoloji, hücre transplantasyonu ve diğer doğum sistemleri ve hastalık etiyolojisi ve tedavisinin aydınlatılması.

The neuroscientist's melting pot: immunology, cell transplantation and other delivery systems, and enlightenment of disease etiology and treatment.

Eve DJ, Sanberg PR.

Neurotox Res · 2008-05-01

DOI: 10.1007/bf03033511PMID: 18522907

Esansiyel titreme: semptomlar ve tedavi.

Essential tremor: symptoms and treatment.

Wick JY, Zanni GR.

Consult Pharm · 2008-05-01

DOI: 10.4140/tcp.n.2008.364PMID: 18540790

Parkinson hastalığının tedavisi için rotigotin transdermal sistem.

Rotigotine transdermal system for the treatment of Parkinson's disease.

Pham DQ, Nogid A.

Clin Ther · 2008-05-01

DOI: 10.1016/j.clinthera.2008.05.007PMID: 18555929

Parkinson hastalığında tedavinin motor kortikal uyarılabilirliğe etkisi.

Effect of therapy on motor cortical excitability in Parkinson's disease.

Soysal A, Sobe I, Atay T, Sen A, Arpaci B.

Can J Neurol Sci · 2008-05-01

DOI: 10.1017/s0317167100008581PMID: 18574929

[Parkinson hastalığı tedavisi 2008].

[Therapy of Parkinson's disease 2008].

Deuschl G.

MMW Fortschr Med · 2008-05-01

PMID: 18678055

İmmünoterapi ve nörodejeneratif bozukluklarda doğal olarak oluşan otoantikorlar.

Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.

Neff F, Wei X, Nölker C, Bacher M, Du Y, Dodel R.

Autoimmun Rev · 2008-05-01

DOI: 10.1016/j.autrev.2008.04.010PMID: 18558370

SİNUCLEINOPATHIES TEDAVİSİ İÇİN KOMPLEOJİ, KOMPOSİTASYON VE YÖNTEMLER

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES

ESPOSITO LUKE, CUMMINGS JOEL, HUDSON F. MICHAEL, SNOW ALAN.

· 2008-04-30

Beyinde östrojen anti-inflamatuar aktivite: menopoz ve nörodejeneratif hastalıklar için terapötik bir fırsat.

Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Vegeto E, Benedusi V, Maggi A.

Front Neuroendocrinol · 2008-04-29

DOI: 10.1016/j.yfrne.2008.04.001PMID: 18522863

Parkinson hastalığı tedavisinde Adenozin A(2A) reseptörleri.

Adenosine A(2A) receptors in Parkinson's disease treatment.

Cieślak M, Komoszyński M, Wojtczak A.

Purinergic Signal · 2008-04-26

DOI: 10.1007/s11302-008-9100-8PMID: 18438720

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16